Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BSI-060T by Pyxis Oncology for Colorectal Cancer: Likelihood of Approval
BSI-060T is under clinical development by Pyxis Oncology and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase...
BSI-060T by Pyxis Oncology for Non-Small Cell Lung Cancer: Likelihood of Approval
BSI-060T is under clinical development by Pyxis Oncology and currently in Phase I for Non-Small Cell Lung Cancer. According to...
BSI-060T by Pyxis Oncology for Kidney Cancer (Renal Cell Cancer): Likelihood of Approval
BSI-060T is under clinical development by Pyxis Oncology and currently in Phase I for Kidney Cancer (Renal Cell Cancer). According...
BSI-060T by Pyxis Oncology for Solid Tumor: Likelihood of Approval
BSI-060T is under clinical development by Pyxis Oncology and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
BSI-060T by Pyxis Oncology for Endometrial Cancer: Likelihood of Approval
BSI-060T is under clinical development by Pyxis Oncology and currently in Phase I for Endometrial Cancer. According to GlobalData, Phase...
BSI-060T by Pyxis Oncology for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
BSI-060T is under clinical development by Pyxis Oncology and currently in Phase I for Head And Neck Squamous Cell Carcinoma...
BSI-060T by Pyxis Oncology for Bladder Cancer: Likelihood of Approval
BSI-060T is under clinical development by Pyxis Oncology and currently in Phase I for Bladder Cancer. According to GlobalData, Phase...
BSI-060T by Pyxis Oncology for Thyroid Cancer: Likelihood of Approval
BSI-060T is under clinical development by Pyxis Oncology and currently in Phase I for Thyroid Cancer. According to GlobalData, Phase...
BSI-060T by Pyxis Oncology for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
BSI-060T is under clinical development by Pyxis Oncology and currently in Phase I for Bile Duct Cancer (Cholangiocarcinoma). According to...